Nitric oxide plays an important role in cardiovascular homeostasis. In this review, the regulation of the three nitric oxide synthase isoforms in the cardiovascular system are examined at molecular and cellular levels. In addition, recent information gleaned from the use of NOS knockout mice are discussed.
Introduction
and cloned [1] . Although its name implies restricted expression to neuronal tissues, it is now well established that nNOS is present outside the central and peripheral Nitric oxide (NO) is a pluripotent regulatory gas in the nervous system and may be involved in several aspects of cardiovascular system generated by the nitric oxide synthcardiovascular control. Recently, it has been shown that ase (NOS) family of proteins. NOSs are NAPDH-requiring NO produced by perivascular nerves of cerebral arteries heme containing oxido-reductases that convert one of the directly modulates vascular tone [2] . In vascular cells, chemically equivalent guanidino nitrogens of L-arginine to expression of nNOS mRNA transcripts and / or immuno-NO and the by product L-citrulline. At least three distinct reactivity, has been shown to occur in endothelial [3] as NOS isoforms exist in mammalian cells: neuronal (nNOS; well as smooth muscle cells of rat and human origin [4, 5] . Type I), inducible (iNOS, Type II) and endothelial (eNOS As is a common theme for all NOS isoforms, the mRNA or Type III). All NOSs have approximately 60% amino and protein is found in cells types where the functional acid identity and very similar primary structures. The role of NO is yet to be discovered. Recently, the presence purpose of this review is to summarize recent developof catalytically active nNOS was shown in vascular ments in the molecular biology and biochemistry of NOS smooth muscle cells of rat carotid arteries. NO production with a special emphasis on the functional roles for NO in from endothelium-denuded carotid arteries (as evidenced the cardiovascular system gleaned from genetic apusing a NOS inhibitor) was enhanced in old, but not young proaches.
spontaneously hypertensive rats (SHR) or WKY controls, suggesting that persistent hypertension unmasks the func-
Regulation of NOS expression:
tional importance of nNOS, ex vivo [4] . The mechanism for this is unclear, as both control and young SHR express 2.1. nNOS nNOS in smooth muscle. Possibly, the gain of nNOS nNOS was the first of the three isoforms to be purified function seen in old SHR may be due to post-translational control mechanisms, such as the loss of a protein inhibitor *Corresponding author. Tel.: 11-203-737-2291; fax: 11-203-737-of nNOS activity, namely PIN [6], CAPON [7] or caveolin 2290. [8, 9] . Additionally, the increased production of NO from nNOS has been shown to mediate dilation of pial arteries approximately 150 kDa, it is unlikely that the testisin eNOS knockout mice, but not in littermate controls [10] .
specific form of nNOS is expressed in these cells. MoreHowever, in this study it is unclear if the increased nNOS over, the expression of another nNOS transcript, nNOSm, expression occurs in vascular cells or in perivascular has been confirmed to occur in skeletal, but not smooth nerves. Finally, there is evidence in human atherosclerotic muscle or in cardiomyocytes [18] . nNOSm contains an lesions that nNOS is expressed in endothelial and mesenextra 102 bp between exons 16 and 17 and in spite of chymal-like intimal cells [11] .
carrying 34 additional amino acids at the carboxy side of the calmodulin binding domain it has similar catalytic 2.2. Transcriptional regulation activity with that expressed in the rat cerebellum and correlates with myotube fusion.
The human nNOS gene occupies approximately 200 kb
In addition to the differences in the 59 UTR of nNOS, of DNA and its major neuronal transcript consists of 29 cassette deletions of exons 9 / 10 and 10 have been exons and 28 introns [12] . The 5'flanking region of this demonstrated in human and murine tissues and human cell gene reveals the presence of multiple potential cis-acting lines [19] . Alternative splicing results in an mRNA species elements such as AP-2, TEF-1 / MCBF, CREB /ATF / c-fos, that is 315 bp shorter (exons 9 / 10). This form is expressed NRF-1, Ets, NF-1 and NF-kB binding motifs. However, its at lower levels in many areas of the nervous system and still unclear which of these elements in the promoter / gives rise to a protein lacking 105 amino acids located at enhancer region, if any, contribute to the transcriptional the amino terminal of the calmodulin-binding domain. This regulation of nNOS expression. Although nNOS is considshorter nNOS protein retains NADPH-diaphorase activity ered a 'constitutively' expressed gene, upregulation of while it is unable to convert arginine to citrulline. Splice nNOS mRNA and protein are thought to be a generalized variants lacking exon 10 have also been described, but are response of neuronal cells to biological, physical or expected to yield an inactive protein since a premature stop chemical stress-inducing stimuli such as spinal cord and codon is introduced. Whether these alternatively spliced nerve injuries, immobilization stress, electrical stimulation, nNOS mRNAs are translated in vivo and can act as and colchicine or formalin administration. Enhanced nNOS 'endogenous dominant negative' alleles remains to be levels coincide temporally and spatially with increased elucidated. Existence of these splice variants has not been levels of the transcription factors c-fos and c-jun. No confirmed in cardiovascular tissue. studies investigating the regulation of nNOS expression in the cardiovascular system has been reported. The reader is 2.4. Post-translational regulation referred to recent reviews for further information on the control of nNOS expression in neuronal tissues [13, 14] .
nNOS has been shown to interact with several proteins that either determine targeting or alter its activity including 2.3. Transcript diversity-alternative splicing.
members of the dystrophin family of proteins [20] , postsynaptic density proteins 93 and 95 [21] , PIN [6], CAPON Molecular diversity of the nNOS gene is manifested by [7] and caveolin-3 [9] in skeletal muscle, neuronal cells or the presence of multiple transcripts. These multiple trantransfected systems. Recently, we have demonstrated that scripts arise from the use of multiple promoters, exon nNOS and caveolin-3 co-distribute in arterial, but not deletions or insertions and the use of alternate polyvenous vascular smooth muscle, suggesting differential adenylation signals. It is now well accepted that two major control of nNOS function in these vascular beds by transcriptional clusters exist within the human nNOS gene, caveolin-3 [22] . the neuronal and the testis-specific cluster. The neuronal nNOS has also been shown to be phosphorylated by a cluster is found upstream of exon 2. At least eight different variety of serine kinases including protein kinase A, first exons are spliced to a common second exon. Since the calmodulin-dependent kinases, and protein kinase C translational start site is found within exon 2, all of these [23, 24] . nNOS in astrocytoma cells is also phosphorylated transcripts should give rise to the same protein [15, 16] .
on tyrosine residues in response to lipopolysaccharide and The testis-specific transcript originates from within intron interferon, suggesting a link between signal transduction 3, giving rise to an mRNA species with a 59 terminus and NOS activation [25] . However, the sites of nNOS encoded for by two new exons spliced to exon 4 of the phosphorylation and the functional significance of this full-length nNOS [17] . as well as in inflammatory cells found in the subendothelition of both sites practically abolished induction by the al space, such as leukocytes, fibroblasts and mast cells.
cytokine mixture in VSM. However, it should be noted that iNOS expression is transcriptionally regulated following the VSM cell line used was unresponsive to LPS stimulacytokine (tumor necrosis factor-a; TNF-a, interleukin-1b;
tion. In addition, the protein binding to the necessary IL-1b, IL-2 or interferon-g; IFN-g) or bacterial NF-kB site was identified as p65 together with an unlipopolysaccharide (LPS) stimulation. In general, cells identified 50kDa protein in VSM. derived from rodents are more easily stimulated to produce NO from iNOS than are human cells, at least in vitro 2.7. Post-transcriptional regulation [26, 27] .
Regulation of iNOS expression at the post-transcription-2.6. Transcriptional regulation al level has also been described. The 39 untranslated region of the iNOS mRNA contains a 'AUUUA' motif which can Most of the work on the transcriptional regulation of potentially destabilize mRNAs. This is reflected by the iNOS expression has been performed using freshly isolated short half-life of the iNOS mRNA in freshly isolated murine macrophages, macrophage cell lines or cultured rat murine macrophages (approximately 3 h); however direct aortic vascular smooth muscle cells (VSM). Expression of demonstration that this motif directs mRNA destabilization iNOS in these cells mediates their cytotoxic actions and is lacking. Potentiation of IFN-g induced iNOS gene plays an important role in the immune response. Cloning expression in RAW 264.7 cells by LPS is due to an of a 1.7 kb fragment flanking the transcriptional start site increase the mRNA half-life from 1.5 h in cells stimulated of the murine gene reveals several putative transcription with IFN-g to 6 h in cells treated with both LPS and factor binding sequences including ten IFN-g response IFN-g. This observation provides a potential molecular elements (IFN-RE), three g-activated sites (GAS), two mechanism for the synergistic effects of LPS with IFN-g. consensus sequences for nuclear factor-kB (NF-kB) bind-
The potentiating actions of IFN on iNOS mRNA levels is ing and four for NF-IL6, two TNF-a response elements similarly seen with cAMP and agents that increase this (TNFa-RE), two activating protein-1 binding motifs (APsecond messenger in cardiac myocytes. 1), three interferon-a stimulated response elements
In contrast to the stabilizing action of LPS on iNOS (ISRE), and a basal transcription recognition site (TATA mRNA levels in IFN-g stimulated macrophages, TGF-b box) [28, 29] . Many of these elements are also present in was shown to decrease iNOS expression by decreasing the human iNOS promoter [30] . mRNA stability. In addition, TGF-b decreases translation In spite of the presence of several putative cis-acting of mRNA without affecting the rate of transcription, and regulatory domains in the iNOS promoter, the importance also increases iNOS protein degradation and activity [35] . of only two of them has been documented to be important Postranscriptional regulation of iNOS expression has also for iNOS induction. The NF-kB site within -76 to -85 of been demonstrated in rat VSM cells as treatment with the murine promoter is essential for LPS-induced iNOS cycloheximide causes a superinduction of iNOS mRNA transcription, with p50 / c-rel and p50 / RelA heterodimers levels by prolonging its half-life from 2-3 h to greater than identified as components of this transacting factor [31] . A 12 h [36] . However, extrapolation of these results in vivo different series of experiments, confirmed that a cluster of are not clear since neither the synergy between LPS and four enhancer elements known to bind IFN-g responsive IFN-g, nor the superinduction by cycloheximide, was transcription factors (-911 to -951) are important for iNOS found in rat aortic strips [37] . TGF-b, inhibits iNOS transcription. Mutagenic analysis and gel shifts revealed induction in VSM similar to its actions in murine macrothat IRF-1 is responsible for this regulation [32] . The phages. However, the only proven action of TGF-b in functional confirmation for the importance of IRF-1 driv-VSM is through a reduction in iNOS transcription, a ing iNOS expression was obtained from mice with targeted mechanism different from that observed in the murine disruption of the IRF-1 gene. Macrophages isolated from macrophages [38] . IRF-1 knockout mice fail to respond to stimulation by increasing iNOS mRNA and nitrite production [33] .
Control of iNOS expression in the rat VSM cell line 2.8. Post-translational regulation A7r5 has been studied [34] . A 1.7 kb 59 upstream fragment of the murine iNOS gene functions as a promoter within Most of the efforts to understand the regulation of this these cells but not as efficiently as in murine macrophages.
NOS isoform have focused on the events leading to A major difference in the behavior of the iNOS promoter transcriptional activation of the iNOS gene. To date, there between VSM and murine macrophages was shown using is no published data demonstrating that iNOS can interact promoter constructs that carried mutations in one or both with other cellular proteins besides calmodulin [39, 40] and NF-kB sites with the upstream site (-962 to -971) being very little on understanding its subcellular trafficking most important for induction in VSM and the downstream [41, 42] . iNOS is phosphorylated in macrophages and this site (-76 to -85) important in murine macrophages. Delemay occur on serine and tyrosine [42, 43] . The specific sites of phosphorylation and its importance in regulation of more complete listing of agents altering eNOS expression iNOS activity are not known.
(see [19] .
The most potent activator of eNOS expression is 2.9. eNOS lysophosphotidylcholine (LPC). LPC content of atherosclerotic blood vessels is higher than that of normal vessels eNOS protein was originally purified and the correand is a major phospholipid found in oxidized low density sponding cDNA cloned from endothelial cells (EC) and is lipoproteins. Treatment of human umbilical vein EC with the NOS isoform responsible for producing the classic LPC initiates a dose-and time-dependent induction of endothelium-derived relaxing factor as described by FurcheNOS mRNA [58] . The magnitude of the mRNA induction gott [44] [45] [46] [47] . Further experimentation has revealed that is 11-fold with a consistent, but not equal, increase in the more cells within the cardiovascular system express eNOS transcription rate of the eNOS gene, as measured in including cardiac myocytes [48] and platelets [49] . In nuclear run-off studies. NOS protein levels, activity and myocytes, locally produced NO may modulate inotropic biologically active NO are all increased with LPC treatand chronotropic state of the heart as NOS inhibitors ment. However, there is a clear discrepancy between the influence the force of contraction and spontaneous rate of levels of eNOS mRNA levels, protein and activity sugbeating in isolated myocytes. Since little in general in gesting complex post-transcriptional and post-translational known about the molecular mechanisms of eNOS expresregulation. These data are consistent with higher levels of sion in different cell types, the regulation of eNOS will be eNOS protein found in atherosclerotic rabbits [59] . The discussed in the context of EC.
stimulatory effects of LPC on eNOS gene expression have been reproduced in other species of EC, albeit to lesser 2.10. Transcriptional and post-transcriptional regulation extent [60] . A recent study has demonstrated that the transcription factor Sp1 is necessary for the actions of Cloning of the human and bovine eNOS genes revealed LPC, since LPC increases the binding of Sp1 to the eNOS a 59 regulatory region containing a 'TATA-less' promoter promoter. Moreover, LPC activates the nuclear serine and a variety of cis elements for the putative binding of phosphatase (PP2A) which is involved with the ability of transcription factors [50, 51] . Specific sites that may in-LPC to induce eNOS expression [61] . fluence basal transcription found in the eNOS gene include
In contrast to the stimulatory effects of LPC on eNOS, Sp1 and GATA sites, whereas potential sites for stimulated Liao et al. reported that oxidized LDL decreases eNOS transcription include a sterol regulatory element (SRE), expression in human EC [62] . At early time points, the activator proteins 1 and 2 elements (AP1, AP2), a nuclear suppression appears to be mediated through a partial factor-1 element (NF-1), partial estrogen responsive eledecrease in the rate of transcription and a destabilization of ments ERE), a cAMP response element (CRE) and a the NOS mRNA whereas at later time points, the rate of putative shear stress response element (SSRE).
transcription increases paradoxically relative to the reducInitial experiments using reporter gene constructs of the tion in steady state mRNA levels. However, the relevance human eNOS promoter reveals that the proximal Sp1 is of greater eNOS expression in atherosclerosis is unknown. necessary for basal transcription [52, 53] . Deletion or site Perhaps, during development of atherosclerosis prior to directed mutagenesis of this site reduces promoter activity lesion formation, LPC induction of eNOS affords protecby 90-95% when transfected into EC. In addition to Sp1 tion against pro-atherosclerotic mechanisms (recruitment of regulating basal transcription, GATA-2 a transcription mononuclear cells and oxidation of low density lipoprofactor highly expressed in EC, also modulates basal teins, LDL) required for the lesion development. The activity. Recently, the expression of the human eNOS ability of lipids derived from LDL and oxidized LDL, per promoter in transgenic mice demonstrates that the promotse, to influence eNOS expression and activity clearly er can direct the expression of the transgene into vascular merits further evaluation. endothelial cells of conduit vessels and large and small A recent discovery germane to the importance of eNOS blood vessels of the heart, brain and skeletal muscle, but in atherosclerosis are the findings that statin based cholesnot to the vasculature of lung or liver [54] . This suggests terol lowering drugs modestly increased eNOS mRNA that additional regulatory elements are required for unilevels by a post-transcriptional mechanism involving form expression in all endothelia and the 1600 bp fragment eNOS mRNA stabilization [63] . The mechanisms for these contains information for regional expression. Several phareffects are not due to the lowering of intracellular cholesmacological agents or physiological situations have been terol levels, per se, but are likely mediated via inhibition of reported to alter eNOS gene expression, such as shear the lipidation of the small GTP binding protein, Rho [64] . stress or exercise training [55] [56] [57] however, the molecular Indeed, mevastatin inhibits the geranyl-geranylation and mechanisms by which they occur are virtually unknown. In subsequent translocation of Rho from the cytosol to the the present review, only agents for which the molecular membrane, an essential step for Rho activation, concomimechanism has been elucidated in some detail are going to tantly with an induction of eNOS mRNA levels. Furtherbe discussed, the reader is referred to recent reviews for a more, stimulation of Rho GTPase decreases eNOS expres- [65] , underscoring the that serine 1179 in bovine eNOS (or 1177 of human fundamental importance of this discovery.
eNOS) is a site of phosphorylation in vitro and in vivo for Additionally TGF-b, tumor necrosis factor-a (TNFa) the serine / threonine kinase Akt (also known as protein and estrogen influence eNOS mRNA levels. TGF-b inkinase B) [89, 90] . Interestingly, the phosphorylation of the duces eNOS mRNA, protein and activity in bovine aortic enzyme renders it more sensitive to calcium / calmodulin EC [66] . Transient transfection assays using bovine eNOS suggesting the introduction of the negative charge in the promoter-reporter constructs demonstrates that the TGF-b carboxy tail influences NOS catalytic function. This reguresponsive element resides between -935 and -1269 nt lation appears to be critically important for both calciumupstream of the transcriptional start site. Gel shift assays dependent and calcium-independent activation of eNOS by and point mutation analysis show that TGF-b increases the diverse stimuli. binding of the CCAAT transcription factor / nuclear factor-1 to the NF-1 site (-1014 to -1026 nt). However, this site is necessary but not sufficient for TGF-b activation of eNOS 3. General perspectives: the use of knockout strains suggesting that additional factors are most likely required.
to address the role of NO in the cardiovascular TNFa down-regulates eNOS activity, protein and mRNA system in endothelial cells [67] . This downregulation has been attributed to destabilization of mRNA that results from
In the past 2 years or so, investigators have been interaction of a TNFa inducible protein that binds to the 39 exploring both old and new functional roles of NO using UTR of eNOS mRNA [68] . Estrogen represents a different gene targeting to disrupt the NOS genes in mice. This class of agents capable of modestly enhancing eNOS genetic approach is very powerful permitting one to expression [69, 70] . Clearly, in vivo, estrogen exerts both examine the basic roles of NO, without the use of rapid non-genomic effects [71,72] and long term transcrippharmacologic agents, which can inhibit all NOS isoforms tional actions on eNOS and more importantly, basal NO or exert other non-specific effects. Interestingly, all three production.
NOS isoforms were successfully disrupted with no particularly obvious embryonic lethality occurring. This was 2.11. Post-translational regulation somewhat disappointing and surprising given the fundamental roles for NO in a variety of basic signaling Optimal NO release from eNOS is known to depend on systems that are relevant during development and posttargeting of this enzyme to Golgi regions and to plasnatal survival. Moreover, combination knockouts, to date, malemal caveolae; events that require both N-myristoylahave not yielded any further information demonstrating an tion and cysteine palmitoylation of the enzyme [73] [74] [75] [76] [77] [78] .
essential role for NO during the processes of embryoThe proper localization of eNOS is likely requisite for the genesis. ability of eNOS to interact with specific proteins that may With this in mind, how do we as investigators in the NO regulate eNOS trafficking or activity. Recently, several field rationalize the importance of NO in almost every proteins -other than calmodulin -have been demonsystem without an essential biological function? Many strated to interact with eNOS in co-precipitation experistudies demonstrating a role for NO in biological systems ments as well as biochemically. Negative regulation of do so by the use of NOS inhibitors bringing up the eNOS occurs by binding to the coat protein of endothelial possibility that these excellent drugs are not as specific as caveola, caveolin-1 [8, 79] or to the intracellular domain once thought. Another relatively simple answer is that (ID4) of G-protein coupled receptors (GPCR) [80] .
compensation for the loss of NOS and NO must occur very Caveolin-1 negatively regulates NOS activity and NO early in life so that the organism survives by controlled production. This occurs via binding of the scaffolding expression of other genes that are functionally redundant domain of caveolin to a caveolin binding domain on eNOS with the NO system. If this is the case, the presence of a [8, 79, 81] . Similar regulation occurs with GPCR. Converseredundant system 'validates' the importance of the NOS ly stimuli such as VEGF, histamine or fluid shear stress gene being deleted. Indeed there is evidence that other cause the recruitment of Hsp90 to eNOS resulting in NOS isoforms may exert a biological role when one activation of eNOS and NO release [82] . The dynamic isoform is deleted [91] [92] [93] . An alternative explanation is interplay between caveolin, GPCR and Hsp90 regulatory that NO, under the most favorable conditions is an proteins are not known.
autacoid, therefore, a modulator of specific pathways in specialized cells. This theory is reasonable since many nNOS knockout mice, to inhibit the vascular isoform cells do not express a NOS isoform or produce NO in vivo eNOS, increased tissue damage. Similar results were or in vitro, but may express NOS once stressed or may obtained in isolated neurons from nNOS knockout mice respond to NO. In this scenario, one can imagine NO as an [100] . These observations taken together with the data important, but non-essential regulator of signaling in from experiments with eNOS knockout mice (see below), specialized NO producing and responding cells. In fact, a suggests neuronal NO exacerbates acute ischemic injury, majority of the phenotypes observed in NOS knockout whereas vascular NO preserves blood flow and protects mice occur post-natally, and support the idea that NO is against damage, thus providing a proof of concept that critical for the ability of fully developed mice to acclimate activation of signaling pathways in the brain generate a to a given cellular response.
neurotoxic species of NO. The protective role of nNOS knockout during ischemic damage was also observed in response to neurotoxicity elicited by malonate and in 4. Phenotypes of isoform specific knockout mice isolated cortical neurons treated N-methyl-D-aspartate (NMDA) [101] . 4.1. nNOS 4.4. iNOS After the identification of nNOS in central and peripheral nerves and the tremendous importance of this isoform in A plethora of evidence is available for the expression of neurotransmission, learning, penile erection and ischemic iNOS in many pathophysiological conditions both in injury based on animal and cell based studies, it was humans as well as in animal models of disease. These anticipated that nNOS knockout mice would possibly die include, but are not limited to, atherosclerosis, balloon in utero, be infertile and lack memory. As always the case injury and restenosis, cardiomyopathy, sepsis, transplant in science, contrary to exceptions, nNOS knockouts were rejection and a variety of disorders associated with acute viable, fertile and able to learn the basics of survival.
and chronic inflammation. Expression of iNOS is thought These mice lack nNOS protein expression in neuronal to have beneficial effects in some conditions due to its tissues and exhibit a pronounced, but not complete, loss in anti-microbial and anti-tumor activities, but may exert NOS catalytic activity in the nervous tissues examined detrimental effects in other conditions such as septic [94] . This residual NOS activity is attributed to novel shock. Mice with targeted disruption of the iNOS locus neuronal NOS isoforms generated by alternative splicing have been generated so far by three groups [102] [103] [104] . All [20] . The only obvious pathological changes were grossly of them have reported that the iNOS knockout mice are distended stomachs reminiscent of pyloric stenosis [94] viable and indistinguishable from wild-type animals in and bladder-urethral sphincter dysfunction [95] . These gross appearance, reproduction, histology of all major effects were likely due to the importance of nNOS derived organs and blood chemistries. As predicted, LPS is unable NO as a non-adrenergic, non-cholinergic transmitter in the to induce iNOS in tissues from iNOS knockout mice. peripheral nervous system [96, 97] .
Role of iNOS in inflammation, sepsis and vascular 4.2. Roles of nNOS in CNS tone
However, after more rigorous analysis, male nNOS Pharmacological experiments have implicated NO in knockout mice show increased aggressive behavior and local inflammatory responses, edema formation and sepsis excess inappropriate sexual behavior [98] . These behaviors [105, 106] . Injection of carrageenin to the footpad of mice were not associated with increased plasma levels of lacking iNOS was accompanied by a smaller degree of testosterone, increased anxiety or impaired olfactory funcswelling than wild-type mice, suggesting that NOS medition. The lack of effect of nNOS gene disruption on ates at least in part, immune inflammation [103] . Intereststandard behaviors is not surprising since these mice ingly, after the administration of LPS to iNOS knockout exhibit normal long-term potentiation (LTP), a paradigm mice, the adhesion and rolling of leukocytes in post for memory and learning [91] . However, double knockout capillary and post-sinusoidal capillaries is markedly enof nNOS and eNOS does reduce LTP in sub-populations of hanced suggesting that iNOS derived NO can exert cytohippocampal neurons [92] .
protection as important negative regulator of leukocyte trafficking in the microcirculation [107] .
Stroke and ischemic injury
In general, it is well recognized that NOS inhibition improves overall hemodynamics and lethality associated One to three days after middle cerebral artery (MCA) with LPS induced shock in rodents. Injection of LPS (1 occlusion, infarct volumes and neurological deficits were mg / kg) into pentobarbital anesthetized wild-type mice reduced in nNOS knockout mice compared to littermate reduced blood pressure rapidly and caused death within 5 h sibs [99] . In addition, administration of L-NAME to the of injection. In contrast, heterozygote and homozygote at Pennsylvania State University on http://cardiovascres.oxfordjournals.org/ Downloaded from knockout mice showed only a 30% and 15% decrease in infection and developed visceral disease. This data taken blood pressure, respectively, and no lethality to the same together, reinforce the important anti-bacterial and antidose of LPS suggesting that iNOS derived NO contributes tumor activities of iNOS-derived NO and suggests that to the actions of LPS [102] . However, plasma levels of isoform selective antagonism of iNOS may increase sustumor necrosis factor-a, interleukin-1b and interleukin-6, ceptibility to infections and dampen immunosurveillance as well as indices of liver function were comparable in mechanisms. both genotypes while NO levels (measured as nitrite) were reduced in iNOS knockout mice. When conscious mice 4.7. eNOS were injected with 5 or 15 mg / kg LPS, iNOS knockout mice were not protected against LPS lethality; however, a
The importance of endothelial derived NO as a regulator higher dose of LPS (30 mg / kg) was not as lethal in of cardiovascular homeostasis stemmed from the seminal knockout mice, suggesting that iNOS deficiency under observations that EDRF [114] is NO [115, 116] , NO some conditions confers partial resistance to LPS [102] .
relaxes blood vessels and inhibits platelet and leukocyte An independent study did not confirm these observations, function and NOS inhibitors increase arterial pressure and since iNOS knockout mice exhibited similar survival after reduce blood flow. Many of these biologic effects were LPS administration [104] . In yet a third study, iNOS null confirmed in eNOS knockout mice. mice showed only a transient reduction in body mass and were completely resistant to the LPS (10 mg / kg)-induced 4.8. Regulation of blood pressure and endothelium lethality [103] . In a different model of septic shock, where dependent vasorelaxation conscious animals are injected with heat-inactivated P. acnes and LPS, iNOS knockout mice did not exhibit eNOS knockouts have been generated by three groups resistance to LPS death [102] . Although differences in the independently and all report that homozygous knockout genetic background of the mice, the generation of knockmice have elevated systemic blood pressures relative to out mice used and in the experimental conditions emcontrol littermates [117] [118] [119] . eNOS knockout mice also ployed may contribute to these disparate findings, it is have mild pulmonary hypertension [120] . An important clear that iNOS derived NO is not the final common 'proof of concept' developed in the eNOS knockout mice mediator of the hemodynamic collapse seen in sepsis.
was the demonstration that acute injection of a L-arginine During sepsis, the induction of iNOS in vascular smooth based NOS inhibitor no longer exerted a pressor response muscle is implicated as a causative factor in the hyin vivo, but paradoxically reduced blood pressure [117] . perdynamic circulation accounting, in part, for the lower-
The lack of a pressor response in eNOS knockouts ing of systemic blood pressure. As mentioned above, there genetically validates the pioneering studies that demon-G is some evidence in support of this in vivo. A recent study strated the long lasting pressor effects of N -mono methyl in vitro has demonstrated that LPS reduces vasoconstrictor L-arginine (L-NMMA) on blood pressure [121, 122] . The responses in isolated carotid arteries from wild-type mice; mechanism of the blood pressure elevation seen in knockan effect completely absent in vessels from iNOS knockout out mice is still under question. The simple answer is that mice [108] . Moreover, the ability of an iNOS inhibitor to the absence of endothelial derived NO increases vascular restore vasomotor tone was not seen in vessels isolated tone causing increased vascular resistance and blood from LPS injected iNOS knockout mice, consistent with a pressure, however, this has not been proven definitively. plethora of pharmacological studies documenting the role Previous studies have implicated NO in renin release of iNOS in conduit vessel reactivity and tone.
which would modulate angiotensin II, a vasoconstrictor and critical regulator of blood pressure. Plasma renin 4.6. Host defense mechanisms levels were almost doubled in the eNOS mutants suggesting that angiotensin generation may contribute to the iNOS derived NO is a double edge sword; it can elevated blood pressure [118] . The reason for the depressor participate in disease processes involving cytokine and actions of a NOS inhibitor on blood pressure in eNOS immune activation and can act as an endogenous inhibitor knockout mice is not obvious but suggests that another in host defenses systems. This latter attribute is a tes-NOS isoform (presumably nNOS) is responsible for the timony to the original work of Hibbs, Stuehr, Nathan and production of NO which modulates a pressor system (i.e. Marletta who discovered that NO is the principal cytotoxic sympathetic nerves, arachidonic acid metabolic pathway) substance produced from activated macrophages [109- important for elevating systemic blood pressure. Recent 112] . To directly test the role of iNOS is host defense, evidence suggests that nNOS-derived NO is indeed the iNOS knockout mice were injected with Leishmania major mediator. Using the selective nNOS inhibitor, 7-nitroand Listeria monocytogenes, respectively [102, 103, 113] .
indazole, blood pressure is reduced in eNOS mutant mice, Wild-type and heterozygous mutant mice achieved spontawhereas the inhibitor had a negligible effect in wild-type neous healing after injection with Leishmania promastimice [123] . In addition, these authors show that the gotes or Listeria whereas mutant mice were susceptible to reduction in blood pressure in eNOS mutants was persis-tent and reversible when nNOS was inhibited chronically. [132] . This was documented by markedly lower blood flow This unexpected role of nNOS manifesting itself in an into the ischemic region and a decrease in capillary density eNOS null background underscores the utility and imporin knockout mice. Moreover, exogenous VEGF administratance of using genetically modified mice in physiological tion or VEGF gene therapy failed to restore angiogenesis in studies. A similar study in isolated pial arterioles showed eNOS knockout mice, supporting the notion that NO is an that the nNOS inhibitor 7-nitroindazole had no effect on essential downstream element regulating VEGF induced vascular responses in wild-type mice, but inhibited Ach angiogenesis in adult mice. The implications of these induced relaxation in eNOS mutant mice, suggesting that findings are tremendous especially for physicians testing eNOS mutants dilate pial arterioles via nNOS as a comthe clinical utility of VEGF for coronary angiogenesis. pensatory adaptive mechanism [10] . As predicted based on the hypertension seen in eNOS knockout mice, Ach induced vasorelaxation of mouse aortic rings was com-5. Summary pletely abrogated [117] . Similar results have been reported in the carotid arterial rings [124] demonstrating that eNOS
Exciting new data elucidating the molecular biology of derived NO is the endothelium derived relaxing factor as NOS regulation will no doubt lead to a greater understandoriginally characterized by Furchgott. ing of how these genes are controlled in normal physiology and disease. The availability of NOS knockout mice will 4.8.1. Vascular remodeling and angiogenesis permit investigators to probe physiological and Previous pharmacological studies have implicated eNOS pathophysiological results of NOS deficiency disease. In in regulation of vascular smooth muscle remodeling in this regard, the generation of tissue specific knockouts, as response to blood flow changes [125] . Recently this has well as inducible knockout mice may reveal unappreciated been proven correct by Rudic et al. who showed that eNOS insights into the functions of NO. Finally, recent evidence knockout mice failed to reduce lumen diameter in response that nNOS and eNOS can interact with other proteins that to a reduction in blood flow [126] . This study demonmay modulate the targeting or activity of these enzymes strated that NO was the endothelium-derived mediator points toward the fascinating, yet subtle nature of how necessary for chronic arterial remodeling [127] . One mammalian cells precisely control the production of NO. provocative finding in this study was the failure to reduce lumen diameter in eNOS knockout was associated with an increase in vessel wall thickness due to vascular smooth Acknowledgements muscle hyperplasia suggesting that eNOS was a mechanosensor transducing hemodynamic changes into bioThis work was supported by grants from National chemical events in the underlying smooth muscle. In a Institute of Health (HL57665 and HL 61371). W.C.S. is an similar study, Moroi et al showed that in response to a cuff Established Investigator of the American Heart Associainjury placed around the femoral artery, eNOS mutant tion. mice developed more severe intimal proliferation compared to wild-type mice [128] . Collectively, these two studies support the idea that endogenous NO is involved with the normalization of vessel shear stress and wall References strain and is an important negative regulator of vascular smooth muscle cell proliferation. eNOS knockout mice exposed to hind limb ischemia did 
